These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 8776723
1. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Dey BR, Frick K, Lopaczynski W, Nissley SP, Furlanetto RW. Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723 [Abstract] [Full Text] [Related]
2. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. Craparo A, O'Neill TJ, Gustafson TA. J Biol Chem; 1995 Jun 30; 270(26):15639-43. PubMed ID: 7541045 [Abstract] [Full Text] [Related]
3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T. Endocrinology; 1997 Feb 30; 138(2):741-50. PubMed ID: 9003010 [Abstract] [Full Text] [Related]
4. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA, Surmacz E. Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064 [Abstract] [Full Text] [Related]
5. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M. Endocrinology; 1996 Oct 01; 137(10):4427-34. PubMed ID: 8828504 [Abstract] [Full Text] [Related]
6. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B, Cheng HL, Margolis B, Feldman EL. J Biol Chem; 1998 Dec 18; 273(51):34543-50. PubMed ID: 9852124 [Abstract] [Full Text] [Related]
8. Evidence for a direct interaction between insulin receptor substrate-1 and Shc. Kasus-Jacobi A, Perdereau D, Tartare-Deckert S, Van Obberghen E, Girard J, Burnol AF. J Biol Chem; 1997 Jul 04; 272(27):17166-70. PubMed ID: 9202037 [Abstract] [Full Text] [Related]
9. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system. Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E. J Biol Chem; 1995 Oct 06; 270(40):23456-60. PubMed ID: 7559507 [Abstract] [Full Text] [Related]
10. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP, Hügl SR, Myers MG, White MF, Reifel-Miller A, Rhodes CJ. Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [Abstract] [Full Text] [Related]
11. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner. Sasaoka T, Ishihara H, Sawa T, Ishiki M, Morioka H, Imamura T, Usui I, Takata Y, Kobayashi M. J Biol Chem; 1996 Aug 16; 271(33):20082-7. PubMed ID: 8702728 [Abstract] [Full Text] [Related]
12. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins. Solow BT, Harada S, Goldstein BJ, Smith JA, White MF, Jarett L. Mol Endocrinol; 1999 Oct 16; 13(10):1784-98. PubMed ID: 10517679 [Abstract] [Full Text] [Related]
13. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B, Leventhal PS, White MF, Feldman EL. Endocrinology; 1998 Dec 16; 139(12):4881-9. PubMed ID: 9832424 [Abstract] [Full Text] [Related]
14. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C, Valverde AM, Kahn CR, Benito M. Diabetes; 2002 Mar 16; 51(3):743-54. PubMed ID: 11872675 [Abstract] [Full Text] [Related]
15. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Valverde AM, Lorenzo M, Pons S, White MF, Benito M. Mol Endocrinol; 1998 May 16; 12(5):688-97. PubMed ID: 9605931 [Abstract] [Full Text] [Related]
16. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T. Curr Biol; 1995 Apr 01; 5(4):404-12. PubMed ID: 7542991 [Abstract] [Full Text] [Related]
17. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Thirone AC, Carvalho CR, Saad MJ. Endocrinology; 1999 Jan 01; 140(1):55-62. PubMed ID: 9886807 [Abstract] [Full Text] [Related]
18. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M. Endocrinology; 2001 Dec 01; 142(12):5226-35. PubMed ID: 11713219 [Abstract] [Full Text] [Related]
19. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling. Goalstone ML, Leitner JW, Berhanu P, Sharma PM, Olefsky JM, Draznin B. J Biol Chem; 2001 Apr 20; 276(16):12805-12. PubMed ID: 11278505 [Abstract] [Full Text] [Related]
20. Negative regulation of insulin-stimulated mitogen-activated protein kinase signaling by Grb10. Langlais P, Dong LQ, Ramos FJ, Hu D, Li Y, Quon MJ, Liu F. Mol Endocrinol; 2004 Feb 20; 18(2):350-8. PubMed ID: 14615605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]